Minneapolis, Minnesota
United States
7
2023-07-27
7
2025-02-04
These are the the leading inventors for applications assigned to Celcuity Inc.:
Celcuity Inc. based in Minneapolis, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Methods of preparing a primary cell sample
#2 | 2023-04-27 ✅ Patent 12,320,799 granted on 2025-06-03Methods of measuring signaling pathway activity for selection of therapeutic agents
#3 | 2023-01-26 ✅ Patent 12,350,276 granted on 2025-07-08METHODS FOR THE TREATMENT OF CANCER USING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA
#4 | 2019-01-24 ✅ Patent 11,333,659 granted on 2022-05-17Methods of measuring signaling pathway activity for selection of therapeutic agents
#5 | 2018-11-08 ✅ Patent 10,976,307 granted on 2021-04-13Whole cell assays and methods
#6 | 2018-08-16 ✅ Patent 11,591,573 granted on 2023-02-28Methods of preparing a primary cell sample
#7 | 2017-03-09 ✅ Patent 11,073,509 granted on 2021-07-27Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent
Also check out Celcuity Inc.'s (Minneapolis, United States) applicant profile with 7 patent applications submitted.
358792 ⎘